Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 23;10:1201007. doi: 10.3389/fnut.2023.1201007

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Janilkarn-Urena, Idrissova, Zhang, VanDreal, Sanghavi, Skinner, Cheng, Zhang, Watanabe, Asatryan, Cadenas and Davies.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

DHM administration ameliorates ethanol-induced changes in circulating and hepatic lipid content and improves aminotransferase levels. DHM effect on levels of circulating: (A) Aspartate aminotransferase (AST) levels (^Ψ0.029, ^ΨΨ0.0006, and ^ΨΨΨ0.024), (B) Alanine aminotransferase (ALT) levels (*0.027, **0.0014, and ***0.0046), (C) Circulating levels of free cholesterol (^#0.0097 and ^##0.0227), (D) Levels of LDL/VLDL are reduced in the DHM group, (E) Levels of cholesteryl esters are increased in the DHM group, (F) Levels of hepatic triglycerides are increased in the DHM group, (G) Levels of circulating triglycerides are reduced in the DHM group (*0.022), and (H) immunoprecipitation of CETP expression is reduced with DHM and levels of LCAT are increased in the group fed DHM.